stem, and cerebellum. Endothelial cells and neurons with activity were proportionately more abundant in neonatal than in adult brains. Although the IE promoter was normally silent in most astrocytes, activity was strongly induced in reactive astrocytes in response to a neocortical stab lesion. The findings support a model, consistent with clinical literature on HCMV encephalitis, whereby tissue damage and gliosis caused by HCMV infection of endothelial and ependymal cells progressively renders adjacent permissive neurons and reactive astrocytes accessible to infection. This transgenic model system should facilitate identification of factors that regulate the HCMV IE promoter with regard to infection permissivity and reactivation from latency.
Key words: HCMV major immediate-early promoter; brainspecific transcription; viral pathogenesis; encephalitis; congenital HCMV infection; AIDS; blood-brain barrier; astrocytes; gliosis Human cytomegalovirus (HCMV), a common herpes virus, establishes permanent residence in the host after primary infection, and viral replication can be periodically reactivated (Alford and Britt, 1990) . Although HCMV rarely causes symptomatic disease in healthy human hosts, when immune mechanisms to neutralize and clear virus from the bloodstream are impaired, opportunistic HCMV infections increase in virulence and persistence. HCMV can be potentially life-threatening in immunodeficient patients and congenitally infected fetuses and infants (Bale, 1984; Klatt and Shibata, 1988; Huang and Kowalik, 1993; Vinters and Ferreiro, 1993; Wiley and Nelson, 1993) . Congenital HCMV infection is the most frequent cause of prenatal injury to the CNS and can result in mental retardation, para-and quadriplegia, spasticity, sensorineural hearing deficits, optic atrophy, and seizure disorders (Saigal et al., 1982; Bale, 1984; Perlman and Argyle, 1992) . HCMV is frequently associated with morbidity and mortality in immunosuppressed bone marrow or organ transplantation pa-tients, cancer patients receiving chemotherapy, and patients with AIDS. HCMV is the most common opportunistic viral agent in AIDS patients and has the essential features of a cofactor in the progression from human immunodeficiency virus (HIV) infection to AIDS (Huang and Kowalik, 1993) . HCMV infections of the CNS can cause necrotizing encephalitis and ependymitis and, in AIDS patients, can result in AIDS dementia complex complicated by cytomegalovirus encephalopathy, a syndrome distinguished by HCMV viremia, intra-blood-brain barrier HCMV antibody production, seizures, coma, and rapid demise (Fiala et al., 1993) . Approximately half of AIDS patients show widespread HCMV infection at autopsy, with ~20% of these demonstrating CNS involvement (Klatt and Shibata, 1988) . This frequency is similar to the 25% frequency of CNS involvement observed for preterm infants with lethal congenital HCMV infections (Perlman and Argyle, 1992) .
Molecular mechanisms that determine cellular permissivity, reactivation, and progressive infection by HCMV are poorly defined. Cell type-specific differences in HCMV immediate-early (IE) transcription are suspected to underlie differences in infection permissivity, because this first phase of viral gene expression is dependent on host cell transcription factors (for review, see Ghazal and Nelson, 1993) . However, analyses of IE promoter segments in gene transfection experiments with cultured cells have largely failed to confirm this hypothesis; the major IE promoter activates high levels of transcription in most cultured cell types, including many that are nonpermissive for HCMV infection. We recently described a transgenic mouse model system for studying HCMV major IE promoter regulation in viva (Koedood et al., 1995) . In the present report, we have used this transgenic model to analyze cell type-specific IE promoter activity in the neonatal and adult brain. The results extend our previously reported correlation between IE promoter specificity in murine tissues and known target cell types of HCMV infection in humans, and provide strong evidence that the IE promoter is a major determinant of cellular permissivity for HCMV infection. In addition, changes in IE promoter activity in the brain during development and during experimentally induced gliosis demonstrate how differentiation cues and tissue damage may play important roles in HCMV infection permissivity and pathogenesis in viva.
MATERIALS AND METHODS
Generution of trunsgenic mice. Transgenic mouse lines HCMV-1 and HCMV-2 carrying IacZ genes linked to the HCMV major IE enhancer/ promoter (-524 to +13 segment; hereafter referred to as the IE promotcr) were generated as described previously (Koedood et al., 1905) . Tissueprepnrtrtion. Transgcne expression in brain cryosections of transgenie (hemirygous) and nontransgenic littermates of HCMV-IE-IacZ transgenic mouse lines HCMV-I and HCMV-2 was analyzed by P-galactosidase (P-Cal) staining and by double immunofluorcscence staining using antibodies against P-Gal and various ccl1 type-specific markers. Mice wcrc deeply anesthetized with chloral hydrate (400 mgikg, i.p.) and perfused through the ascending aorta with 4% paraformaldehyde in 0.15 M phosphate buffer, pH 7.4. Brains were removed immcdiatcly after perfusion; post-fixed in the same tixativc for 3 hr, and stored overnight in 10% dimethvlsulfoxidc in PBS for crvonrotection (Fritschv cl , . al., 1994) . Sections (40 km) wcrc cut from frozen blocks with a sliding microtomc and collected in PBS. p-&l s/uini~ Free-floating sections were washed 3 times for 5 min in PBS and incubated for 4 hr at 30°C in P-Gal stain solution with Bluo-Gal substrate (Gibco, Gaithcraburg, MD) prepared as described previously (Koedood ct al., 1095) . The stained sections were washed 5 min in PBS, transferred briefly through dHzO, and mounted onto gelatin-coated slides, air-dried, post-fixed 5 min in 4% paraformaldehydc in PBS, and washed 5 min in PBS before countcrstaining with neutral red and mounting coverslips out of xylcne. For whole-mount staining of the leptomeningcs, brains from perfused neonatal mice were bisected sagittally, washed 3 times for 20 min in PBS, and stained 4 hr at 30°C in P-Gal stain solution. They were then washed 15 min in PBS and post-fixed overnight in 4% paraformaldehydc in PBS before photography. The P-Gal activity was detected primarily in cell nuclei, attributable to the fusion of a nuclear localization signal in frame with the 1ucZ transgene used to prepare thcsc transgcnic mice.
Immunoperoxidase staining. Free-floating sections were incubated overnight in primary antibody (rabbit anti-P-Gal Nr. 0631-0002, Cappel, West Chester, PA) diluted 15000 in PBS containing 2% normal strum and 0.2% Triton X-100, and then processed for the avidin-biotin-peroxidase method of Hsu ct al. (1981) according to the specifications of the manufacturer (Vectastain Elite kits, Vector Laboratorics, Burlingame, CA), using diaminobcnzidinc hydrochloride as chromogen. Stained sections were mounted on gelatin-coated slides, air-dried, dehydrated in ascending series of ethanol, and coverslipped out of xylene.
Immunqfluorescence r/aining. Colocalization of P-Gal-positive nuclei with neuronal markers [microtubule-associated protein 2 (MAP-2) (Matus et al., 1981) and GABA, rcccptor p2,3 subunits (Richards et al., 1987) ] and with astroglial markers [glial fibrillary acid protein (GFAP) (Bignami et al., 1980) and calcium-binding protcin SIOOP (Boycs et al., 19X6) ] were analyzed by double immunotluoresccnce staining. For this purpose, sections were incubated overnight with a mixture of primary antibodies (e.g., P-Gal and MAP-2) diluted in PBS containing 2% normal serum and 0.2% Triton X-100, washed three times with PBS, and incubated for 30 min with secondary antibodies coupled either to dichlorotriazinylaminofluorescein (1:lOO) or carboxymethylindocyanine (Cy3) (1: 200; Jackson Immunoresearch, West Grove, PA). Selectivity was ensured by using primary antibodies raised in different species. Controls for specificity were performed by omitting one of the primary antibodies during the overnight incubation. The sections were then mounted on gelatin-coated glass slides, air-dried, covcrslipped with buffered glycerol, and analyzed by confocal laser microscopy (Leica TCS 4D, Nussloch, Germany).
Cortictrl lesion. A stab lesion was made unilaterally under stereotaxic control in the frontal cortex of transgenic mice and nontransgenic control littermates. The mice were deeply anesthetized by intraperitoneal administration of ketamin (100 mg/kg) and xylacin (16 mg/kg) before the operation. Lesioncd mice and unlesioned controls were perfused at various time points (0,6, and 12 hr, and 1,3, and 6 d), and the brains were processed for immunohistochemistry with P-Gal and GFAP antibodies as described above. All animal procedures were performed according to the Swiss animal protection laws and the principles of laboratory animal care (National Institutes of Health publ. No 85-23).
RESULTS

Identification
of brain regions and cell types with HCMV IE promoter activity The cell type-specific activity of the HCMV IE promoter was analyzed by P-Gal staining and immunohistochemical analysis of brain tissue from neonatal and older mice of transgenic lines HCMV-1 (Figs. 1,2) and HCMV-2 (latter not shown) carrying ZucZ genes driven by the IE promoter -524 to + 13 segment. The qualitative similarity in IE promoter specificity in these two lines during embryogenesis has been described previously (Koedood et al., 1995) . In the brain, IE promoter activity was observed in nearly identical sites and cell types in the two transgenic lines, but, as in embryonic tissues, HCMV-1 line mice yielded consistently stronger expression compared with HCMV-2 line mice in almost all the sites of activity. One activity site in HCMV-1 mice that did not appear in HCMV-2 mice was the thalamus. This difference was also apparent during embryogcncsis, with HCMV-1 embryos showing unique activity in the ventral midbrainidiencephalon beginning at 10.5 d postcoitus (Koedood et al., 1995) . The otherwise high concordance between the two lines confirms that, with the exception of the thalamus, the 1ucZ expression patterns observed with these mice are bona fide representations of the innate specificity of this IE promoter segment in viva.
Anti-P-Gal immunostaining of brain sections from both newborn (postnatal day 0, or PO) (Fig. 1A) and 5-week-old HCMV-1 mice (Fig. 1B) revealed IE promoter activity in non-neuronal structures that included the leptomeninges (Fig. lC,D) , ependymal, and choroid plexus epithelia (Fig. lF) , and in several discrete neuronal populations in the forebrain, brainstem, and cerebellum ( Fig. l/l&E) .
Expression in presumptive endothelial cells (Fig.  1G ) was widespread in neonatal brains (Fig. L4,C) , particularly in the pia mater (Fig. lC,D) , but was less evident in sections of more mature mice (Fig. IB) .
Immunofluorescent double-labeling analysis with antibodies against p-Gal and various cell type-specific markers indicated that in most locations, nonendothelial cells with IE promoter activity were predominantly neurons rather than astrocytes ( Fig. 2A-C) . GFAP-or SlOOP-positive astrocytes with P-Gal immunoreactivity wcrc rarely seen (Fig. 20) , and glial cells in white matter (oligodendrocytes) were always P-Gal-negative (data not shown). The regional distribution of neurons with IE promoter activity was similar at different stages of postnatal development, but, as was also the case for endothelial cells, the proportion of positive neurons was significantly higher in newborn mice than in older mice (in Fig. 1 , compare PO section in A with 5 week section in B). The distribution of brain nuclei with positive neurons is summarized in Table 1 . In mice at 5 weeks of age, a prominent labeling of neurons was observed in the olfactory bulb, hippocampus CA1 and CA3 subfields, deep cortical layers, thalamus, granule cell layer and deep nuclei of the cerebellum, and several brainstem structures (Fig. 1B) . The proportion of labeled neurons varied Figure 1 . Distribution of cells with HCMV IE promoter activity in the brain of neonatal (PO, A and E; P2, C and D) and 5 week-old mice (B, F, G), as visualized by P-Gal histochemical staining (C, 0, G) or by immunoperoxidase staining with anti-P-Gal antibodies (A, B, E, F). High densities of positive nuclei are evident in specific brain regions (arrowheads in A and B), especially at PO. The labeling is also prominent in the leptomeninges, as seen in a P2 whole-brain mount (C) or in an isolated fragment of pia-arachnoid (D), where positive nuclei are clearly associated with blood vessels. On the cellular level, positive nuclei are evident, for instance, in neurons of deep cortical layers (E); in the choroid plexus and ependyma (F; the U~WVS point to weakly positive ependymal cell nuclei); and in presumptive endothelial cells lining a brain microvessel (G). Abbreviations: 5, motor nucleus of the trigeminal nerve; 7, facial motor nucleus; cp, cortical plate; CPU, caudate-putamen; IC, inferior colliculus; T/z, thalamus; V, cerebral cortex layer V; Vr, cortical layer VI. Scale bars: A-C, 1 mm; D, 250 pm; E, 50 hrn; F, 20 pm; G, 10 Frn.
greatly among the various brain regions, and there was considerable regional selectivity in their distribution. Apart from the thalamus, where IE promoter activity was not independently confirmed in HCMV-2 mice, the highest proportions of labeled neurons were seen in brainstem motor nuclei and in certain sensory afferent nuclei, such as the cochlear and vestibular nuclei. In other nuclei, such as the spinal trigeminal nucleus, only a few scattered positive neurons could be detected. Antibodies against the neuron-specific markers MAP-2 (A, C) and GABA, receptor p2,3 sub1 inits (B) and against the astrocyte-specific marker GFAP (D-G) were combined with P-Gal antibodies in double immunofluorescence staining experiments to identify cell types exhibiting HCMV IE promoter activity. The images corresponding to each antigen were digitized simultaneously using different filter combinations, color-coded, and superimposed. In all cases, the P-Gal immunofluorescence is shown in red, whereas the neuronal or astrocytic marker immunofluorescence is shown ingreen. The selective neuronal localization of HCMV IE promoter activity in normal adult brain is depicted for the hippocampus CA3 subfield (A), cerebellum (B), and deep cortical layers (C). The armwhead in A points to a presumptive endothelial cell nuclei (flattened profile). The lack of expression in astrocytes is illustrated for the CA1 subfield of the hippocampus (D), where all p-Gal-positive nuclei are located in the pyramidal cell layer (py). By contrast, prominent HCMV IE promoter (P-Gal-positive) activity is present in GFAP-positive reactive astrocytes 6 d after a stab lesion in frontal cortex, as shown in E-G. E and F depict the colocalization of P-Gal and GFAP immunoreactivity in cortical reactive astrocytes in the vicinity of the lesion (F) and in the ipsilateral parietal cortex (E). In certain cases, the P-Gal staining was so intense that it spread into the finest processes of the astrocyte (awow in F). Amwheads in E point to presumptive neuronal nuclei (larger, round), which are also present in the control hemisphere. G depicts double-labeled astrocytes in the caudate-putamen ipsilaterally to the lesion. In both normal and lesioned brains, microglia were P-Gal-negative (data not shown). gr, Granule cell layer of the cerebellum; PC, Purkinje cell layer; py, pyramidal cell layer of the hippocampus; wm, white matter. Scale bars, 20 pm. Overall, the cell type specificity of the IE promoter in the mouse brain was highly consistent with known targets of HCMV infection in the human CNS (see Discussion) with one notable exception. Our analysis of normal brains failed to show IE promoter activity in astrocytes despite the fact that these cells are among the known infection targets in HCMV encephalitis in humans (Vogel, 1958; Wiley et al., 1986; Wiley and Nelson, 1988) . Interestingly, a study by Poland et al. (1990) has shown that cultured astroglial cell types (including primary explants and several tumor-derived lines) vary greatly in their ability to express HCMV antigens and in their support of HCMV replication. In view of these observations, it occurred to us that astrocytes infected by HCMV in viva may have become permissive during the course of gliosis, the reactive astrocytosis process that typically accompanies diverse neurological insults, including viral infections of the CNS. Gliosis is a common feature of HCMV infection in the brain (Haymaker et al., 1954; Wiley and Nelson, 1988; Vinters et al., 1989) . Thus, we reasoned that changes in gene expression in activated astrocytes, exemplified by induction of GFAP (Eng and Ghirnikar, 1994) , might lead to activation of the IE promoter and subsequent permissivity for HCMV infection.
We tested this idea experimentally in the following way. A stab lesion was made unilaterally in the frontal cortex of anesthetized transgenic mice and nontransgenic littermate controls. The mice recovered without incident and were killed for brain histology at various time points during the ensuing course of gliosis and lesion repair. Immunohistochemical analysis of brain sections was performed using antibodies against P-Gal and GFAP, a standard marker to identify reactive astrocytes during gliosis. This experiment revealed a striking and prolonged induction of IE promoter activity in the cerebral cortex of lesioned HCMV-1 transgenic mice. The induction was not evident at 0 or 6 hr postlesion, but was first detected at 12 and 24 hr in a few cells scattered in and around the lesion site (data not shown). The number of cells with P-Gal-positive nuclei near the lesion increased dramatically over the next 2 d (3 d time point; Fig. U) . Anti-GFAP antibody staining identified the cytoplasmic processes of reactive astrocytes distributed in a pattern similar to that of the P-Gal-positive nuclei (in Fig. 3, compare B to A) . At the 6 d time point, numerous P-Gal-positive cells were observed around the lesion site (Fig. 3C) and, in addition, positive cells were scattered throughout the entire ipsilateral (lesioned side) cortex (Fig. 3C,E) and also in the underlying striatum (Fig. 30 . Interestingly, none of Figure 3 . Induction of HCMV IE promoter activity in the ipsilateral cerebral cortex and caudate-putamen after a stab wound in the cortex. Enhanced HCMV IE promoter activity parallels the gliosis, as visualized by immunoperoxidase staining for P-Gal and GFAP, respectively. A, B, Lesion site after 3 d survival. The highly localized distribution of P-Gal-positive nuclei (A) closely matches that of GFAP-positive glial cells (B) around the lesion. C depicts the increase in HCMV IE promoter activity seen ipsilaterally 6 d after the lesion [open awow on the lesioned side &es)] compared with the contralateral, nonlesioned side (C@l of the same animal. Notice the broad distribution of P-Gal-positive nuclei throughout the ipsilateral cortex and underlying caudate-putamen (CPU; arrows), but not in the globus pallidus (GP; arrow/read). The lesion-induced increase in P-Gal and GFAP staining in the ipsilateral cerebral cortex seen after 6 d survival is depicted in panels E and G, respectively; the P-Gal and GFAP staining in the contralateral, control side, is shown in D and F, respectively. Arrowheads in D point to rare positive neuronal nuclei on the control side; arrows in E point to dramatically enlarged astrocytes where the P-Gal immunostaining spreads into the processes (see Fig. 2E for a higher magnification of such a cell) . There is only very weak basal GFAP staining in cerebral cortex on the control side (arrowhead in F), whereas on the lesioned sides reactive astrocytes are distributed evenly throughout all cortical layers. H and I illustrate the increase in HCMV IE promoter activity in the caudate-putamen on the lesioned side (T) compared with the unlesioned side (H). See Figure 2G for identification of these cells as astrocytes. ac, Anterior commissure; Pir, piriform cortex. Scale bars: A-B and D-Z, 200 pm; C, 500 pm. the animals tested showed changes in the ipsilateral hippocampus or in the contralateral (unlesioned side) hemisphere with regard to either P-Gal-or GFAP-positive cells. Thus, at all time points tested (up to 6 d), the contralateral hemisphere of the lesioned mice (Fig.   3C,D,F,H) appeared much like the unlesioned controls (latter not shown).
Immunofluorescent double-labeling analysis with anti-GFAP and anti-P-Gal antibodies revealed that the majority, if not all, of the cells showing inducible IE promoter activity in the lesioned brains were reactive astrocytes, strongly positive for GFAP (Fig. 2E-G ). The few P-Gal-positive nuclei present in GFAP-negative cells in these sections had the typical size and morphology of neuronal nuclei, and likely represented neurons that were already P-Gal-positive before lesioning. A similar proportion of P-Gal-positive neurons was also seen in the contralateral hemisphere and in unlesioned controls. The double-labeling analysis also revealed that reactive astrocytes were not entirely homogeneous with regard to IE promoter induction because a fraction of the GFAP-positive astrocytes remained P-Galnegative. Near the lesion (cl mm), these P-Gal-negative astrocytes represented -20% of all GFAP-positive astrocytes. Their proportion increased to -35% in areas of the cortex distant from the lesion (>3 mm). Finally, there was no evidence for the induction of IE promoter activity in other cell types, notably endothehal cells or microglial cells in the lesioned brains.
DISCUSSION
In the study presented here, we have shown that the HCMV major IE promoter (-524 to +13 segment) is active in rcstrictcd sites and cell types in brains of transgcnic mice. Cell types that were competent to activate the IE promoter included some endothelial cells, ependymal cells, choroid plexus cpithelia, and discrete neuron populations in the deep cortex, hippocampus, cerebellum, thalamus, brainstem, and olfactory bulb. The proportions of endothelial cells and neurons with activity were greater in neonatal than adult brains. Although the IE promoter was notably inactive in most astrocytes in the normal adult brain, it was inducible in reactive astrocytes during gliosis in response to a cortical lesion. Gliosis, an astrocytic response to diverse neurological insults, is a typical finding in HCMV encephalitis (Haymaker et al., 1954; Eng and Ghirnikar, 1994) . The cell type-and differentiation status-dependent activity of the IE promoter documented here is highly consistent with known features of HCMV infection permissivity in culture and in viva (Lathey et al., 1990; Poland et al., 1990; Fiala et al., 1993) . In autopsied brain tissue from individuals dying of fatal infection, cytomegalic cells (HCMV-infected cells that are characteristically enlarged and contain Cowdry type A viral inclusion bodies) have been noted in endothelial cells, ependymal and choroid plexus epithelia, and in astrocytes and neurons (Haymaker et al., 1954; Klatt and Shibata, 1988; Nelson, 1988, 1993; Vinters et al., 1989; Fiala et al., 1993; Vinters and Ferreiro, 1993) . Sites of infection frequently noted in congenital and adult HCMV encephalitis include leptomeningeal blood vessels, choroid plexus, and ependymal and subependymal (subventricular) regions; less frequently, infection has also been observed in the granule cell layer of the cerebellum, caudate-putamen, pallidurn, thalamus, and olfactory bulb (Worth and Howard, 1950; Haymaker et al., 1954; Wiley et al., 1986; Vinters et al., 1989) . Together with our previous work showing correlation between sites of IE promoter activity in transgenic mouse embryos and known target tissues of congenital HCMV infection in human fetuses (Koedood et al., 1995) , the present analysis extends this correlation to specific cell types and regions in the neonatal and adult brain. The data provide strong evidence that cell type specificity of the IE promoter is conserved between humans and mice and that this promoter plays a major role in determining cellular permissivity for HCMV infection in humans.
Although it has been long suspected that the interaction between host cell transcription factors and the major IE promoter plays an important role in HCMV infection permissivity, gene transfection experiments with cultured cells have confused this issue by paradoxically suggesting that the IE promoter is highly active in most cell types. In contrast, we have observed restricted activity of the IE promoter in viva. More importantly, the in viva cell type specificity of the IE promoter correlates well with known targets of HCMV infection in humans. Based on this correlation, it appears that transgenic mice constitute a more relevant probative system than transfected cultured cells for studying IE promoter regulation as it pertains to HCMV infections in viva.
Among the cell types able to activate IE promoter transcription in the brain, endothelial cells represent key targets of HCMV infection with regard to encephalopathies because they maintain the tight junction blood-brain barrier, which normally blocks entry of virus into the CNS. Infected endothelial cells have been strongly implicated as major disseminators of virus during systemic HCMV infections (Vogel, 1958; Grefte et al., 1993; Waldman et al., 1995) . In AIDS patients, HCMV infection of endothclial cells is bclicvcd to facilitate entry and dissemination of HIV in the CNS by causing a breakdown in the blood-brain barrier and attracting HIV-infcctcd inflammatory cells (macrophages and multinucleated giant cells) into the brain (Wiley and Nelson, 1993) . Thereafter, HCMV and HIV may act synergistically to cause particularly severe encephalopathies Skolnik et al., 1988; Ho et al., 1990) . Histopathological analysis of HCMV-infected brain tissue suggests that HCMV can spread from the leptomeninges into underlying tissue via microvasculature to cause focal subdural damage (frequently seen in AIDS patients with HCMV encephalitis), and also can spread from the brain ventricles in a ventriculofugal manner (from ependyma into adjacent subependymal regions) (Haymaker et al., 1954; Wiley and Nelson, 1988; Vinters et al., 1989) . Because a recent in vitro study suggests that efficient transmission of HCMV requires direct celhcell contact (Waldman et al., 1995) it seems likely that ventricular spread of HCMV infection may be preceded by infection of the choroid plexus, where ventricular ependymal cells are uniquely juxtaposed to a rich bed of endothelial cells and choroid plexus epithelia.
HCMV also has been implicated in other nervous system pathologics that involve destruction of blood-nerve or blood-brain barriers, including Guillain-Barre syndrome-like polyneuropathies that have been observed in previously healthy individuals after HCMV mononucleosis (Bale, 1984; Fiala et al., 1993) , and Rasmussen's encephalitis, a form of childhood epilepsy caused by autoimmune antibodies against glutamate receptors (Rogers et al., 1994; Jay et al., 1995; Twyman et al., 1995) . HCMV DNA has been detected by polymerase chain reaction in brain tissue from 8 of 10 patients with Rasmussen's encephalitis (and in 0 of 5 controls with other types of encephalitis), and has been postulated to be an important cofactor by causing chronic blood-brain barrier disruption that allows leakage of antiglutamate receptor antibodies into the brain (Jay et al., 1995) .
Several families of DNA-binding transcription factors, including CAMP response element binding, NFKB/rel, and retinoic acid receptor factors have been implicated in activation of the IE promoter in various cell types (for review, see Ghazal and Nelson, 1993) . The delayed in viva induction that we have characterized in astrocytes likely represents dependence on de nova synthesis of transcription factors or on the relatively slow decay of a repressor. Given the similarity in induction kinetics for the IE and GFAP promoters in reactive astrocytes, it is possible that the two promoters are regulated via the same signal transduction pathway(s). Relevant signaling molecules may include interleukin and TGF-/3 family cytokines that are known to be released in response to stab lesioning and to have effects on transcription of the GFAP promoter (Brenner, 1994) . Interestingly, we have observed that the IE promoter is activated in cortical slice cultures of the HCMV-IE-ZucZ transgenic mice (unpublished data), indicating that experimental approaches using organ and slice cultures may be useful for studying IE promoter regulation in response to growth factors and cytokines.
In conclusion, this transgenic analysis provides compelling evidence that cell type-specific regulatory proteins that act on the IE promoter are significant determinants of HCMV infection specificity in the brain. Expansion of potential infection targets by IE promoter induction as exemplified in reactive astrocytes is likely to play an important role in progression of HCMV encephalitis and in opportunistic infection strategies used by HCMV in other tissues as well. This transgenic system should facilitate identification of cellular transcription factors that repress or activate the IE promoter in viva and thereby affect permissivity for HCMV infection.
